SAFETY INFO

Important Safety Information

Singfiller is only intended for use as an intradermal implant.
Do not inject intravascularly. As for other injectable medical devices, inadvertent injection into blood vessels could potentially lead to vascular occlusion, ischemia and necrosis. Aspiration prior to injection is recommended.
If blanching is observed, i.e, the overlying skin turns a whitish color, the injection should be stopped at once and the area massaged until it returns to a normal color.
Do not use in patients with bleeding disorders or in patients who are taking thrombolytics or anticoagulants.
Do not resterilize Singfiller
Do not mix with other products prior to injection of the device.

Contraindications

• Pregnant women, lactating women, and minors should be used with caution.
• Patients with a history of severe allergic reactions and patients with multiple history of severe allergies are contraindicated.
• Patients with abnormal clotting mechanisms or patients who have been treated with thrombolytics, anticoagulants, or platelet aggregation inhibitors within two weeks are contraindicated.
• Disabled in the following situations:
  　The site where permanent fillers have been injected is banned; the site where non-permanent fillers have been used within 6 months has been disabled; the site where fillers have been injected but the type is not clear has been banned; active dermatoses, inflammations, infections and related diseases The site or its vicinity is disabled.